The Living Community in Your Mouth — and Why Biofilm Is Not What Most People Think

“The microbe is nothing. The terrain is everything.” — Louis Pasteur, father of modern microbiology and germ theory, whose final insight — that the body’s internal environment matters as much as the pathogen itself — anticipated everything modern biofilm science has since confirmed.

The First Person to See It

In 1683, a Dutch draper named Antonie van Leeuwenhoek scraped the white matter from between his own teeth, placed it under a microscope he had ground himself, and became the first human being in history to observe bacteria. What he saw astonished him. He wrote to the Royal Society of London that there were more living creatures in the scum between his teeth than there were men in his entire kingdom.

He was not wrong. And he was looking at the earliest recorded observation of what we now call oral biofilm.

Three and a half centuries later, most patients still do not know what biofilm is. They have heard of plaque. They have heard of tartar. But biofilm — the living, organized, chemically communicating microbial ecosystem that forms on every surface in the mouth and connects to systemic disease in ways that medicine is only now beginning to fully document — remains almost entirely outside the conversation that most people have with their dental provider.

This blog is that conversation.

Biofilm vs. Plaque: Why the Distinction Matters

Most people use the words plaque and biofilm interchangeably. They are not the same thing, and the difference matters enormously for how we understand oral disease and how we treat it.

Dental plaque in the conventional sense refers to the soft, sticky film that accumulates on tooth surfaces between brushing — a mixture of bacteria, food particles, and saliva proteins. Left undisturbed, it hardens over time as calcium and phosphate from saliva crystallize into it, becoming calculus, or tartar — the mineralized deposit that only a dental instrument can remove. This is what most people think of when they think of a dental cleaning: the removal of plaque and calculus.

Biofilm is something more fundamental than either of these. It is not simply an accumulation of bacteria on a surface. It is a structured, organized community of microorganisms — bacteria, fungi, viruses, and archaea — that have collectively made the decision to stop living as free- floating individual cells and instead attach to a surface, secrete a protective matrix around themselves, and operate as a unified biological entity. That protective matrix — made of polysaccharides, proteins, lipids, and extracellular DNA — is what makes biofilm so clinically challenging. It is not merely a physical barrier. It is a biological shield that actively protects the community within it from immune cells, from antibiotics, from antimicrobial rinses, and from

the mechanical action of a toothbrush.

Within that matrix, bacteria communicate through chemical signals in a process called quorum sensing — essentially voting on collective behaviors based on population density. When enough bacteria are present, the biofilm activates virulence factors, increases acid production, and shifts its composition toward the more pathogenic species that drive disease. A mature, established biofilm can be up to 1,000 times more resistant to antibiotics than the same bacteria living as individual cells in suspension.

This is not plaque. This is an organized biological community with its own internal governance, its own immune evasion strategies, and its own systemic agenda.

What Oral Biofilm Actually Does to the Body

The mouth is not a sealed environment. It is the most colonized entry point into the body, and every time we swallow — which happens approximately 2,000 times per day — we introduce whatever is living in our oral biofilm into the rest of the system. The consequences of a dysbiotic oral biofilm — one in which harmful species have come to dominate — extend well beyond the teeth and gums.

Periodontal disease and bone loss. When pathogenic species within biofilm release inflammatory byproducts below the gum line, they trigger a chronic immune response in the surrounding tissue. The immune system, attempting to contain the infection, releases enzymes and cytokines that inadvertently destroy the collagen and bone supporting the teeth. This is periodontitis — and it is, at its biological root, a disease driven by what is living in the subgingival biofilm.

Systemic inflammation. Oral biofilm dysbiosis triggers a state of low-grade systemic inflammation through two pathways. The first is direct: pathogenic bacteria and their metabolic byproducts enter the bloodstream through inflamed gum tissue, traveling to organs and tissues throughout the body. The second is indirect: the chronic immune activation in the periodontium trains immune cells to remain in a heightened inflammatory state, affecting the entire system’s inflammatory baseline. This low-grade inflammation is now understood to be a contributing factor in diabetes, Alzheimer’s disease, adverse pregnancy outcomes, respiratory infections, and

rheumatoid arthritis.

The cardiovascular connection — a 2025 landmark finding. In August 2025, researchers published a study in the Journal of the American Heart Association that represents perhaps the most direct evidence yet of a causal link between oral biofilm and heart disease. Examining arterial plaques from 121 sudden death victims and 96 surgical patients, they found oral viridans streptococcal biofilm — the same bacteria that live in the mouth — inside coronary arterial plaques in 65% of sudden death cases and 58% of surgical patients. What made the finding extraordinary was not merely the presence of oral bacteria in arterial tissue, but that the biofilm had actively evaded immune detection — hiding inside the arterial wall, remaining dormant for years, and then potentially activating to contribute to the inflammation and rupture of

atherosclerotic plaques that cause heart attacks. This is not a correlation. It is a mechanism.

The oral biofilm is not staying in the mouth. It is traveling.

What Makes Biofilm Worse — and Why It Matters

Biofilm is not a fixed entity. Its composition, its virulence, and its systemic impact are all influenced by the conditions in which it lives — and those conditions are shaped by choices and circumstances that most patients have never connected to their oral health.

Dry mouth. Saliva is the mouth’s primary antimicrobial defense. It contains immunoglobulins, lactoferrin, lysozyme, and a range of other antimicrobial proteins that constantly police the oral environment, limiting pathogenic overgrowth and maintaining the pH balance that favors beneficial bacteria. When salivary flow decreases — a condition known as xerostomia — that defense collapses, and the biofilm shifts rapidly toward dysbiosis. Dry mouth is extraordinarily common, and its most frequent cause is medication. Antihistamines, antidepressants, antihypertensives, diuretics, muscle relaxants, and dozens of other commonly prescribed drugs list reduced salivary flow as a side effect. Patients who take these medications are managing a silent oral health risk that most of them have never been told about.

Stress. Cortisol — the body’s primary stress hormone — directly alters salivary composition, reducing the concentrations of the antimicrobial proteins that keep biofilm in check. Chronically elevated cortisol also suppresses the immune surveillance that limits pathogenic biofilm growth. Patients who grind at night, who carry jaw tension through the day, who sleep poorly — these are not separate complaints. They are the same story, and the oral biofilm is part of it.

Simple carbohydrates and sugar. Acid-producing bacteria within biofilm metabolize simple sugars preferentially, producing the acids that erode enamel and shift the oral pH toward an environment that favors pathogenic species. Frequent exposure to sugar and refined carbohydrates does not merely feed decay — it actively selects for the most dangerous members of the biofilm community, accelerating dysbiosis with every exposure.

Digestive disorders. The gut and the mouth are in continuous conversation. GERD —

gastroesophageal reflux disease — introduces gastric acid into the oral environment repeatedly, altering pH and biofilm composition. Gut dysbiosis, which is associated with IBD, IBS, Crohn’s disease, and a growing list of other conditions, is bidirectionally linked to oral dysbiosis. Patients with chronic digestive issues frequently have oral biofilm profiles that reflect the same imbalance.

Salivary gland dysfunction. Sjögren’s syndrome, radiation therapy to the head and neck, aging, and certain autoimmune conditions can impair the salivary glands’ ability to produce adequate flow, with the same consequences as medication-induced dry mouth.

Poor oral hygiene. When biofilm is not mechanically disrupted on a regular basis, it matures. In its early stages, it remains relatively soft and disruption-responsive. As it ages — within 48 to 72 hours — it reorganizes into more complex, layered structures that are increasingly resistant to removal. After approximately two weeks, it begins to mineralize into calculus. The window for easy mechanical disruption is narrow, which is why the timing and thoroughness of daily hygiene matters more than most patients realize.

What Makes Biofilm Better

The same logic that explains how biofilm worsens also points toward what supports a healthier oral ecosystem.

Hydration. Adequate water intake is the simplest and most consistently overlooked support for salivary flow. Patients who are chronically mildly dehydrated — which is more common than most people recognize — often experience reduced saliva production without any obvious symptoms. Drinking sufficient water throughout the day, including water rather than acidic or sugary drinks, maintains the salivary flow that the oral ecosystem depends on.

Oral probiotics. As we have written about extensively in our previous blogs, oral probiotics — strains specifically selected to colonize the mouth rather than the gut — work through several mechanisms to support a healthier biofilm community. They compete with pathogenic bacteria for the same attachment sites on tooth and gum surfaces. They produce bacteriocins — natural antimicrobial compounds — that specifically suppress harmful species. They modulate the immune response in the surrounding tissue, reducing the inflammatory burden that dysbiotic biofilm creates. And when combined with saliva testing, which identifies each patient’s specific microbial landscape, they can be personalized to address the particular imbalances present in that individual’s mouth. At Dr. Rossinski Dental Health, we use Bristle saliva testing to guide probiotic recommendations — because a generic probiotic blend and a targeted one are not the same intervention.

Xylitol. This naturally occurring sugar alcohol, found in birch trees and certain fruits, is metabolized by the acid-producing bacteria in biofilm — specifically Streptococcus mutans — but cannot be used as an energy source the way regular sugar can. The bacteria take it in, begin to process it, find they cannot complete the metabolic cycle, and effectively starve. Regular xylitol exposure — through gum, mints, or specific oral care products — has been shown to reduce Streptococcus mutans populations and shift the biofilm toward a less cariogenic composition.

Guided Biofilm Therapy. When it comes to professional removal of biofilm, GBT has become the gold standard — and we will cover it in full in the next blog. Unlike traditional cleaning, which addresses the visible consequences of biofilm, GBT is designed around biofilm as the primary target. It reaches below the gum line, removes biofilm without damaging enamel or cementum, and leaves the oral environment in the best possible condition for beneficial bacteria to reestablish. For patients who want the most effective professional support for a healthier biofilm ecosystem, GBT is where that conversation begins.

Seeing What Was Invisible — Disclosing Agents and the Future of Biofilm Detection

For most of dental history, biofilm was managed by inference. You could not see it directly — you could only see its consequences: the bleeding, the recession, the cavities, the calculus that formed when it had been left in place long enough.

Disclosing agents have changed that relationship between patient and biofilm in a way that nothing else can. These are safe, color-revealing solutions — typically containing erythrosine, fuchsin, or a two-tone formulation — that are applied to the teeth and bind selectively to bacterial biofilm. What is invisible under normal light suddenly becomes visible in vivid color, revealing exactly where biofilm has accumulated, how mature it is, and which surfaces are being missed by the patient’s daily hygiene routine. Two-tone disclosing agents go further still, staining new, thin biofilm in one color and older, more established biofilm in another — giving both the clinician and the patient a real-time map of the oral ecosystem’s most vulnerable areas.

The clinical value of disclosing agents is not merely diagnostic. When patients see their own biofilm for the first time — the patches on the back molars they thought they were brushing, the accumulation at the gum line they had no idea was there — it changes their relationship with their own oral hygiene in a way that no verbal instruction can replicate. Education through visibility is among the most powerful tools in preventive dentistry.

Technology is extending this principle further. Quantitative light-induced fluorescence — QLF — uses blue light to excite porphyrins produced by bacteria within mature biofilm, causing them to emit a characteristic red fluorescence that reveals biofilm distribution and density with greater precision than conventional disclosing agents. The GBT disclosing system, which we will cover in the next blog, works on a related principle — making biofilm visible in color-coded stages before any instrument touches the teeth, so that the cleaning that follows is targeted rather than generalized.

Beyond the mouth, the question of what oral biofilm is doing to the rest of the body is also becoming measurable. Neko Health, a preventive health scanning service, offers comprehensive cardiovascular assessment including arterial health evaluation, skin imaging, blood biomarkers, and metabolic profiling — all in a single one-hour appointment. For patients who want to understand the systemic picture that oral biofilm may be contributing to — particularly cardiovascular and inflammatory markers — Neko represents a genuinely forward-thinking complement to what we assess in the dental chair.

GBT: The Treatment That Finally Addresses Biofilm at Its Source

Traditional dental cleaning addresses the visible consequences of biofilm — the calculus, the surface staining, the tissue damage that has already occurred. It does not address the biofilm itself, particularly below the gum line, where the subgingival biofilm that drives periodontitis lives largely undisturbed by any conventional polishing instrument.

Guided Biofilm Therapy changes this. We will cover GBT in full in our next blog, but the

essential point belongs here: GBT is the first clinical protocol designed specifically around biofilm as the primary target of preventive care. It begins by making biofilm visible, proceeds with erythritol powder removal that is non-abrasive and selective, and reaches below the gum line through the Perioflow subgingival tip into the pocket where no polishing instrument has gone before. It is, in the most literal sense, prophylactic treatment aimed at the origin of disease rather than its aftermath.

Pasteur was right. The microbe alone is not the problem. The terrain — the biofilm ecosystem in which microbes live, organize, and either thrive in balance or tip into dysbiosis — is where the real conversation about oral health begins.

To learn more about biofilm, saliva testing, oral probiotics, or Guided Biofilm Therapy, book an appointment at Dr. Rossinski Dental Health online or at (212) 673-3700 or

inform@rossinski.com.

References

1. Van Leeuwenhoek A. Letter to the Royal Society of London, 1683. Describing the first microscopic observation of oral bacteria.

2. Karhunen P, et al. “Viridans streptococcal biofilm evades immune detection and

contributes to inflammation and rupture of atherosclerotic plaques.” Journal of the

American Heart Association. 2025;14:e041521.

3. Chopra A, et al. “Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data.” Scientific Reports. January 2024.

4. Xiao Y, et al. “The oral microbiome and atherosclerosis: current evidence on association, mechanisms, and clinical implications.” Frontiers in Immunology. October 2025.

5. Esmed.org. “Oral Biofilms and their connection to cardiovascular health.” Medical Research Archives, Vol. 13, No. 5. May 2025.

6. Frontiers in Microbiology. “Probiotics, Prebiotics, Synbiotics, Postbiotics, and Bioactive Agents in Modulating Harmful Oral Biofilms.” 2025.

7. PMC. “Strategies to Combat Caries by Maintaining the Integrity of Biofilm and

Homeostasis during the Rapid Phase of Supragingival Plaque Formation.” 2022.

8. PMC. “Local and systemic effects of probiotic modulation of the oral microbiota.” 2026.

9. Neko Health. “Neko Health Scan.” nekohealth.com/us/en/health-scan